 Christopher Lowry
Concepts (653)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Serotonin | 60 | 2022 | 296 | 10.800 |
Why?
| | Raphe Nuclei | 41 | 2019 | 110 | 9.870 |
Why?
| | Tryptophan Hydroxylase | 34 | 2022 | 52 | 6.540 |
Why?
| | Anxiety | 45 | 2023 | 853 | 5.070 |
Why?
| | Serotonergic Neurons | 16 | 2022 | 24 | 4.860 |
Why?
| | Mycobacterium | 12 | 2023 | 103 | 4.820 |
Why?
| | Stress, Psychological | 35 | 2021 | 974 | 4.770 |
Why?
| | Mycobacteriaceae | 11 | 2023 | 21 | 4.440 |
Why?
| | Dorsal Raphe Nucleus | 14 | 2023 | 27 | 3.730 |
Why?
| | Neurons | 43 | 2022 | 1298 | 3.680 |
Why?
| | Proto-Oncogene Proteins c-fos | 23 | 2019 | 181 | 3.600 |
Why?
| | Amygdala | 21 | 2022 | 179 | 3.540 |
Why?
| | Fear | 16 | 2023 | 297 | 3.530 |
Why?
| | Corticotropin-Releasing Hormone | 18 | 2018 | 78 | 3.520 |
Why?
| | Rats | 79 | 2022 | 5034 | 3.280 |
Why?
| | Behavior, Animal | 25 | 2023 | 472 | 3.180 |
Why?
| | Corticosterone | 24 | 2021 | 248 | 3.060 |
Why?
| | Gastrointestinal Microbiome | 15 | 2023 | 503 | 3.030 |
Why?
| | Microbiota | 15 | 2023 | 652 | 2.990 |
Why?
| | Animals | 165 | 2023 | 32102 | 2.650 |
Why?
| | Stress Disorders, Post-Traumatic | 14 | 2023 | 758 | 2.400 |
Why?
| | Receptors, Corticotropin-Releasing Hormone | 9 | 2019 | 33 | 2.320 |
Why?
| | Rats, Wistar | 34 | 2020 | 368 | 2.250 |
Why?
| | Anti-Inflammatory Agents | 9 | 2023 | 448 | 2.150 |
Why?
| | Hyperthermia, Induced | 6 | 2023 | 65 | 2.140 |
Why?
| | Inflammation | 26 | 2023 | 2499 | 2.070 |
Why?
| | Antidepressive Agents | 9 | 2023 | 195 | 2.040 |
Why?
| | Extinction, Psychological | 4 | 2023 | 80 | 2.010 |
Why?
| | Depressive Disorder, Major | 9 | 2023 | 304 | 1.980 |
Why?
| | Central Nervous System | 10 | 2022 | 239 | 1.870 |
Why?
| | Pituitary-Adrenal System | 11 | 2019 | 162 | 1.850 |
Why?
| | Hypothalamo-Hypophyseal System | 12 | 2019 | 197 | 1.830 |
Why?
| | Mental Health | 6 | 2023 | 571 | 1.810 |
Why?
| | Anxiety Disorders | 11 | 2021 | 310 | 1.800 |
Why?
| | Brain | 27 | 2022 | 2370 | 1.750 |
Why?
| | Rats, Sprague-Dawley | 31 | 2022 | 2262 | 1.710 |
Why?
| | Serotonin Plasma Membrane Transport Proteins | 11 | 2022 | 72 | 1.680 |
Why?
| | Panic Disorder | 7 | 2017 | 20 | 1.610 |
Why?
| | Organic Cation Transport Proteins | 9 | 2021 | 26 | 1.530 |
Why?
| | Male | 126 | 2024 | 55949 | 1.450 |
Why?
| | Motor Activity | 12 | 2021 | 633 | 1.410 |
Why?
| | Microglia | 6 | 2023 | 203 | 1.400 |
Why?
| | Glucocorticoids | 6 | 2023 | 552 | 1.320 |
Why?
| | Bacterial Vaccines | 4 | 2018 | 61 | 1.320 |
Why?
| | Fluoxetine | 6 | 2023 | 46 | 1.280 |
Why?
| | Lipopolysaccharides | 6 | 2023 | 826 | 1.270 |
Why?
| | Citalopram | 2 | 2018 | 27 | 1.220 |
Why?
| | Analysis of Variance | 23 | 2018 | 1227 | 1.210 |
Why?
| | Social Isolation | 3 | 2013 | 54 | 1.210 |
Why?
| | Hypothalamus | 6 | 2019 | 150 | 1.210 |
Why?
| | Urocortins | 10 | 2019 | 19 | 1.180 |
Why?
| | Depressive Disorder | 3 | 2018 | 336 | 1.170 |
Why?
| | Carbolines | 9 | 2015 | 27 | 1.170 |
Why?
| | Probiotics | 2 | 2018 | 47 | 1.170 |
Why?
| | Body Temperature Regulation | 7 | 2019 | 69 | 1.150 |
Why?
| | Environment, Controlled | 3 | 2016 | 19 | 1.150 |
Why?
| | Vaccines, Inactivated | 3 | 2018 | 68 | 1.150 |
Why?
| | Neural Pathways | 12 | 2020 | 260 | 1.130 |
Why?
| | Tryptophan | 8 | 2022 | 136 | 1.110 |
Why?
| | Salamandridae | 11 | 2009 | 26 | 1.110 |
Why?
| | Disease Models, Animal | 20 | 2023 | 3580 | 1.100 |
Why?
| | Mood Disorders | 3 | 2013 | 117 | 1.090 |
Why?
| | Depression | 10 | 2023 | 1145 | 1.070 |
Why?
| | Immunomodulation | 3 | 2016 | 85 | 1.070 |
Why?
| | Dysbiosis | 2 | 2018 | 146 | 1.060 |
Why?
| | Immunohistochemistry | 20 | 2019 | 1642 | 1.030 |
Why?
| | Cell Count | 14 | 2015 | 305 | 1.020 |
Why?
| | Serotonin Receptor Agonists | 5 | 2017 | 27 | 1.010 |
Why?
| | Anti-Anxiety Agents | 5 | 2023 | 44 | 1.010 |
Why?
| | Hippocampus | 8 | 2022 | 709 | 1.000 |
Why?
| | RNA, Messenger | 9 | 2020 | 2574 | 0.970 |
Why?
| | Panic | 4 | 2017 | 11 | 0.960 |
Why?
| | Stress, Physiological | 11 | 2014 | 399 | 0.930 |
Why?
| | Dorsomedial Hypothalamic Nucleus | 3 | 2015 | 5 | 0.910 |
Why?
| | Arousal | 6 | 2023 | 153 | 0.890 |
Why?
| | Veterans | 7 | 2024 | 1233 | 0.870 |
Why?
| | Receptor, Serotonin, 5-HT1A | 8 | 2019 | 39 | 0.870 |
Why?
| | Septal Nuclei | 3 | 2019 | 17 | 0.860 |
Why?
| | Brain Injuries, Traumatic | 4 | 2020 | 301 | 0.860 |
Why?
| | Maternal Deprivation | 4 | 2019 | 15 | 0.860 |
Why?
| | Mental Disorders | 8 | 2022 | 902 | 0.840 |
Why?
| | Caffeine | 5 | 2018 | 58 | 0.840 |
Why?
| | Inflammation Mediators | 3 | 2018 | 479 | 0.830 |
Why?
| | Reflex, Startle | 4 | 2019 | 58 | 0.830 |
Why?
| | Social Behavior | 7 | 2022 | 269 | 0.820 |
Why?
| | Hot Temperature | 3 | 2022 | 303 | 0.820 |
Why?
| | Neurons, Afferent | 4 | 2012 | 88 | 0.810 |
Why?
| | Carbon Dioxide | 4 | 2010 | 211 | 0.810 |
Why?
| | RNA, Ribosomal, 16S | 10 | 2022 | 489 | 0.810 |
Why?
| | Prefrontal Cortex | 3 | 2018 | 267 | 0.800 |
Why?
| | Immunization | 9 | 2022 | 401 | 0.790 |
Why?
| | Cytomegalovirus Infections | 1 | 2023 | 182 | 0.780 |
Why?
| | Feces | 5 | 2023 | 372 | 0.780 |
Why?
| | Hydroxyindoleacetic Acid | 11 | 2018 | 19 | 0.780 |
Why?
| | Veterans Health | 2 | 2024 | 165 | 0.770 |
Why?
| | Colitis | 4 | 2019 | 226 | 0.740 |
Why?
| | Mice | 32 | 2023 | 15052 | 0.710 |
Why?
| | Exploratory Behavior | 5 | 2021 | 86 | 0.710 |
Why?
| | Mice, Inbred BALB C | 12 | 2023 | 1168 | 0.700 |
Why?
| | Cerebrospinal Fluid Proteins | 1 | 2020 | 10 | 0.700 |
Why?
| | Emotions | 5 | 2023 | 477 | 0.680 |
Why?
| | Humans | 83 | 2024 | 115587 | 0.680 |
Why?
| | Environment Design | 2 | 2016 | 24 | 0.680 |
Why?
| | Toxoplasmosis | 4 | 2024 | 31 | 0.680 |
Why?
| | Body Temperature | 4 | 2018 | 211 | 0.660 |
Why?
| | Locomotion | 6 | 2021 | 81 | 0.660 |
Why?
| | Synaptic Transmission | 4 | 2018 | 232 | 0.660 |
Why?
| | Interleukin-4 | 1 | 2020 | 209 | 0.650 |
Why?
| | Serotonin Agents | 4 | 2015 | 8 | 0.650 |
Why?
| | Dominance-Subordination | 2 | 2011 | 16 | 0.630 |
Why?
| | Physical Conditioning, Animal | 2 | 2019 | 191 | 0.610 |
Why?
| | Genes, fos | 2 | 2010 | 36 | 0.610 |
Why?
| | Catecholamines | 3 | 2005 | 97 | 0.600 |
Why?
| | Housing, Animal | 2 | 2016 | 45 | 0.600 |
Why?
| | Blood Proteins | 1 | 2020 | 238 | 0.600 |
Why?
| | Behavior | 1 | 2018 | 91 | 0.590 |
Why?
| | Gene Expression Regulation | 9 | 2018 | 2353 | 0.590 |
Why?
| | Swimming | 3 | 2021 | 45 | 0.590 |
Why?
| | 8-Hydroxy-2-(di-n-propylamino)tetralin | 1 | 2017 | 9 | 0.580 |
Why?
| | Circadian Rhythm | 4 | 2021 | 371 | 0.580 |
Why?
| | Gastrointestinal Tract | 1 | 2019 | 168 | 0.580 |
Why?
| | Hypothermia | 1 | 2017 | 38 | 0.580 |
Why?
| | Vaccination | 3 | 2020 | 1209 | 0.570 |
Why?
| | Military Personnel | 3 | 2019 | 525 | 0.570 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2013 | 794 | 0.570 |
Why?
| | Hypercapnia | 4 | 2012 | 50 | 0.560 |
Why?
| | Lipid Metabolism | 1 | 2020 | 449 | 0.560 |
Why?
| | Psychological Trauma | 1 | 2017 | 55 | 0.560 |
Why?
| | Toxoplasma | 3 | 2024 | 33 | 0.550 |
Why?
| | Social Determinants of Health | 1 | 2018 | 136 | 0.550 |
Why?
| | Parvalbumins | 2 | 2020 | 19 | 0.540 |
Why?
| | Immune System | 2 | 2014 | 173 | 0.530 |
Why?
| | Brain Concussion | 2 | 2020 | 469 | 0.530 |
Why?
| | Organic Anion Transporters, Sodium-Independent | 2 | 2019 | 4 | 0.500 |
Why?
| | Vasotocin | 4 | 2000 | 5 | 0.490 |
Why?
| | Gene Expression | 7 | 2020 | 1435 | 0.480 |
Why?
| | Hormone Replacement Therapy | 1 | 2015 | 77 | 0.470 |
Why?
| | Post-Concussion Syndrome | 1 | 2017 | 155 | 0.470 |
Why?
| | Conditioning, Classical | 5 | 2020 | 87 | 0.460 |
Why?
| | Cytokines | 7 | 2023 | 1853 | 0.460 |
Why?
| | Proteomics | 1 | 2020 | 859 | 0.460 |
Why?
| | Immobility Response, Tonic | 1 | 2013 | 4 | 0.460 |
Why?
| | Intestines | 2 | 2014 | 324 | 0.440 |
Why?
| | Interleukin-6 | 4 | 2023 | 677 | 0.440 |
Why?
| | Sex Characteristics | 2 | 2013 | 641 | 0.440 |
Why?
| | T-Lymphocytes, Regulatory | 3 | 2016 | 342 | 0.440 |
Why?
| | Public Health | 2 | 2022 | 438 | 0.440 |
Why?
| | Adaptation, Psychological | 3 | 2014 | 551 | 0.430 |
Why?
| | Mesencephalon | 2 | 2010 | 57 | 0.430 |
Why?
| | Pons | 2 | 2010 | 30 | 0.430 |
Why?
| | Life Style | 2 | 2014 | 429 | 0.420 |
Why?
| | Cold Temperature | 1 | 2013 | 128 | 0.420 |
Why?
| | Mice, Inbred C57BL | 12 | 2022 | 4773 | 0.420 |
Why?
| | GABA Antagonists | 6 | 2013 | 32 | 0.420 |
Why?
| | Time Factors | 12 | 2015 | 6165 | 0.410 |
Why?
| | gamma-Aminobutyric Acid | 3 | 2017 | 151 | 0.400 |
Why?
| | GABAergic Neurons | 1 | 2012 | 22 | 0.400 |
Why?
| | Prosencephalon | 6 | 2018 | 48 | 0.400 |
Why?
| | Cushing Syndrome | 1 | 2011 | 10 | 0.400 |
Why?
| | Kynurenine | 5 | 2018 | 80 | 0.390 |
Why?
| | Dose-Response Relationship, Drug | 12 | 2015 | 1870 | 0.380 |
Why?
| | Rats, Long-Evans | 6 | 2021 | 100 | 0.380 |
Why?
| | Breast Neoplasms | 1 | 2022 | 1872 | 0.380 |
Why?
| | Socioeconomic Factors | 2 | 2014 | 1086 | 0.380 |
Why?
| | Porphyromonas gingivalis | 2 | 2022 | 17 | 0.380 |
Why?
| | Suicide | 4 | 2020 | 501 | 0.370 |
Why?
| | Brain Mapping | 5 | 2007 | 521 | 0.370 |
Why?
| | Bronchi | 1 | 2012 | 250 | 0.370 |
Why?
| | Female | 35 | 2024 | 59913 | 0.360 |
Why?
| | Third Ventricle | 1 | 2010 | 14 | 0.360 |
Why?
| | Light | 3 | 2008 | 337 | 0.360 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 2 | 2023 | 145 | 0.350 |
Why?
| | Suicide, Attempted | 3 | 2019 | 316 | 0.350 |
Why?
| | Animals, Newborn | 5 | 2018 | 780 | 0.350 |
Why?
| | Cognition | 4 | 2022 | 980 | 0.340 |
Why?
| | Interneurons | 1 | 2010 | 99 | 0.340 |
Why?
| | Fenfluramine | 1 | 2009 | 13 | 0.330 |
Why?
| | Prebiotics | 2 | 2021 | 23 | 0.330 |
Why?
| | Amish | 2 | 2019 | 7 | 0.320 |
Why?
| | TRPV Cation Channels | 1 | 2008 | 28 | 0.320 |
Why?
| | Chromatography, High Pressure Liquid | 7 | 2018 | 477 | 0.310 |
Why?
| | Pets | 2 | 2018 | 20 | 0.310 |
Why?
| | Brain Chemistry | 4 | 2007 | 116 | 0.310 |
Why?
| | Medulla Oblongata | 4 | 2012 | 33 | 0.310 |
Why?
| | Sexual Behavior, Animal | 4 | 2006 | 49 | 0.310 |
Why?
| | RNA, Bacterial | 2 | 2020 | 173 | 0.300 |
Why?
| | Schizophrenia | 3 | 2016 | 418 | 0.300 |
Why?
| | Sleep Deprivation | 2 | 2020 | 166 | 0.290 |
Why?
| | Age Factors | 7 | 2021 | 2907 | 0.290 |
Why?
| | Encephalitis | 2 | 2020 | 127 | 0.290 |
Why?
| | Periaqueductal Gray | 3 | 2017 | 15 | 0.290 |
Why?
| | T-Lymphocytes, Helper-Inducer | 1 | 2008 | 129 | 0.290 |
Why?
| | Relaxin | 2 | 2018 | 15 | 0.290 |
Why?
| | Proto-Oncogene Proteins c-fyn | 1 | 2007 | 12 | 0.290 |
Why?
| | Neuropeptides | 3 | 2018 | 65 | 0.290 |
Why?
| | Allosteric Site | 1 | 2007 | 16 | 0.280 |
Why?
| | Vaccines | 1 | 2012 | 376 | 0.280 |
Why?
| | Rats, Inbred F344 | 4 | 2019 | 245 | 0.280 |
Why?
| | Limbic System | 1 | 2007 | 43 | 0.280 |
Why?
| | Aging | 4 | 2022 | 1631 | 0.270 |
Why?
| | Maze Learning | 6 | 2021 | 87 | 0.270 |
Why?
| | Histamine | 2 | 2006 | 65 | 0.270 |
Why?
| | Receptors, GABA-A | 1 | 2007 | 88 | 0.270 |
Why?
| | Restraint, Physical | 4 | 2015 | 92 | 0.270 |
Why?
| | Indomethacin | 1 | 2006 | 75 | 0.270 |
Why?
| | 5-Hydroxytryptophan | 5 | 2022 | 22 | 0.270 |
Why?
| | Up-Regulation | 4 | 2012 | 820 | 0.270 |
Why?
| | Benzodiazepines | 1 | 2007 | 115 | 0.260 |
Why?
| | Cyclooxygenase Inhibitors | 1 | 2006 | 72 | 0.260 |
Why?
| | Receptors, Serotonin, 5-HT3 | 1 | 2005 | 15 | 0.260 |
Why?
| | Biguanides | 1 | 2005 | 12 | 0.260 |
Why?
| | Telemetry | 2 | 2017 | 35 | 0.260 |
Why?
| | In Situ Hybridization | 5 | 2012 | 298 | 0.260 |
Why?
| | Hypothalamic Area, Lateral | 1 | 2005 | 2 | 0.260 |
Why?
| | Prolactin | 2 | 2005 | 95 | 0.260 |
Why?
| | Antibodies, Protozoan | 3 | 2024 | 29 | 0.250 |
Why?
| | Bacteria | 3 | 2020 | 729 | 0.250 |
Why?
| | Environmental Microbiology | 2 | 2019 | 42 | 0.250 |
Why?
| | Vimentin | 1 | 2005 | 57 | 0.250 |
Why?
| | Life Change Events | 1 | 2005 | 135 | 0.240 |
Why?
| | Adrenal Medulla | 1 | 2004 | 7 | 0.240 |
Why?
| | Dopamine | 3 | 2018 | 237 | 0.240 |
Why?
| | Macrophages | 2 | 2023 | 1284 | 0.230 |
Why?
| | Fibroblast Growth Factor 8 | 2 | 2014 | 27 | 0.230 |
Why?
| | Adjuvants, Pharmaceutic | 1 | 2023 | 10 | 0.230 |
Why?
| | Helicobacter Infections | 2 | 2021 | 25 | 0.230 |
Why?
| | Neuroimmunomodulation | 2 | 2019 | 71 | 0.230 |
Why?
| | Cerebral Cortex | 1 | 2007 | 386 | 0.230 |
Why?
| | Tuberculosis, Bovine | 1 | 2023 | 3 | 0.230 |
Why?
| | Mice, Inbred Strains | 2 | 2023 | 399 | 0.230 |
Why?
| | Diazepam | 1 | 2023 | 27 | 0.220 |
Why?
| | Paraventricular Hypothalamic Nucleus | 2 | 2018 | 36 | 0.220 |
Why?
| | Suicidal Ideation | 2 | 2019 | 399 | 0.220 |
Why?
| | Immunoglobulin G | 4 | 2024 | 781 | 0.210 |
Why?
| | Adult | 18 | 2022 | 30718 | 0.210 |
Why?
| | Friends | 1 | 2023 | 46 | 0.210 |
Why?
| | Adjuvants, Immunologic | 1 | 2023 | 206 | 0.210 |
Why?
| | Mucins | 1 | 2022 | 61 | 0.210 |
Why?
| | Receptors, Neuropeptide | 2 | 2012 | 11 | 0.210 |
Why?
| | Random Allocation | 4 | 2009 | 337 | 0.200 |
Why?
| | Coinfection | 1 | 2023 | 120 | 0.200 |
Why?
| | Planets | 1 | 2021 | 1 | 0.200 |
Why?
| | Hydrazines | 3 | 2018 | 28 | 0.200 |
Why?
| | Norepinephrine | 5 | 2005 | 207 | 0.200 |
Why?
| | Serotonin Antagonists | 2 | 2015 | 30 | 0.200 |
Why?
| | Diet, High-Fat | 2 | 2022 | 225 | 0.200 |
Why?
| | Neopterin | 2 | 2022 | 9 | 0.200 |
Why?
| | Helicobacter pylori | 1 | 2021 | 30 | 0.190 |
Why?
| | Piperazines | 3 | 2010 | 314 | 0.190 |
Why?
| | Populus | 1 | 2021 | 9 | 0.190 |
Why?
| | Hygiene | 2 | 2014 | 28 | 0.190 |
Why?
| | Frailty | 1 | 2024 | 116 | 0.190 |
Why?
| | Cholera Toxin | 3 | 2013 | 28 | 0.190 |
Why?
| | Adrenalectomy | 2 | 2015 | 80 | 0.190 |
Why?
| | Groundwater | 1 | 2021 | 33 | 0.190 |
Why?
| | Carrier Proteins | 1 | 2005 | 701 | 0.190 |
Why?
| | Brain Stem | 3 | 2006 | 102 | 0.180 |
Why?
| | Microdialysis | 5 | 2019 | 50 | 0.180 |
Why?
| | Escape Reaction | 2 | 2017 | 61 | 0.180 |
Why?
| | Temporomandibular Joint | 1 | 2020 | 10 | 0.180 |
Why?
| | Multiple Trauma | 1 | 2021 | 90 | 0.180 |
Why?
| | Epinephrine | 2 | 2005 | 167 | 0.180 |
Why?
| | Mycobacterium tuberculosis | 1 | 2023 | 271 | 0.180 |
Why?
| | In Vitro Techniques | 3 | 2009 | 1044 | 0.180 |
Why?
| | Receptors, G-Protein-Coupled | 2 | 2012 | 192 | 0.180 |
Why?
| | Bile Acids and Salts | 1 | 2021 | 172 | 0.180 |
Why?
| | United States | 6 | 2024 | 12295 | 0.180 |
Why?
| | Gain of Function Mutation | 1 | 2020 | 31 | 0.180 |
Why?
| | Shock | 1 | 2021 | 76 | 0.180 |
Why?
| | Seasonal Affective Disorder | 1 | 2020 | 9 | 0.170 |
Why?
| | Communicable Diseases | 1 | 2022 | 130 | 0.170 |
Why?
| | DNA, Bacterial | 2 | 2020 | 309 | 0.170 |
Why?
| | Neuropsychiatry | 1 | 2020 | 15 | 0.170 |
Why?
| | Receptors, Calcitriol | 1 | 2020 | 53 | 0.170 |
Why?
| | Autoradiography | 2 | 2009 | 71 | 0.170 |
Why?
| | United States Department of Veterans Affairs | 2 | 2024 | 557 | 0.170 |
Why?
| | Periodontitis | 1 | 2020 | 42 | 0.170 |
Why?
| | Middle Aged | 10 | 2020 | 26999 | 0.170 |
Why?
| | Individuality | 2 | 2019 | 146 | 0.170 |
Why?
| | Central Amygdaloid Nucleus | 1 | 2019 | 5 | 0.170 |
Why?
| | Psycholinguistics | 1 | 2019 | 17 | 0.170 |
Why?
| | Mice, 129 Strain | 1 | 2019 | 77 | 0.170 |
Why?
| | Phobic Disorders | 1 | 2019 | 25 | 0.160 |
Why?
| | Sleep Disorders, Circadian Rhythm | 1 | 2019 | 39 | 0.160 |
Why?
| | Memory, Episodic | 1 | 2019 | 38 | 0.160 |
Why?
| | Mice, Knockout | 4 | 2019 | 2604 | 0.160 |
Why?
| | Animal Assisted Therapy | 1 | 2018 | 9 | 0.160 |
Why?
| | Mycobacterium Infections, Nontuberculous | 1 | 2023 | 337 | 0.160 |
Why?
| | Autism Spectrum Disorder | 2 | 2020 | 322 | 0.160 |
Why?
| | Hypothalamus, Middle | 2 | 2010 | 2 | 0.160 |
Why?
| | Alarmins | 1 | 2018 | 26 | 0.160 |
Why?
| | Yohimbine | 2 | 2010 | 11 | 0.150 |
Why?
| | Adiponectin | 1 | 2020 | 214 | 0.150 |
Why?
| | MicroRNAs | 2 | 2014 | 607 | 0.150 |
Why?
| | Biomarkers | 3 | 2024 | 3466 | 0.150 |
Why?
| | Housing | 1 | 2019 | 114 | 0.150 |
Why?
| | Nervous System | 1 | 1998 | 63 | 0.150 |
Why?
| | HMGB1 Protein | 1 | 2018 | 48 | 0.150 |
Why?
| | Biogenic Monoamines | 2 | 2009 | 13 | 0.150 |
Why?
| | Nesting Behavior | 1 | 2018 | 16 | 0.150 |
Why?
| | Vasopressins | 1 | 1998 | 57 | 0.150 |
Why?
| | Phenylalanine | 1 | 2018 | 58 | 0.150 |
Why?
| | Vertebrates | 1 | 1998 | 56 | 0.150 |
Why?
| | Grooming | 2 | 2009 | 4 | 0.150 |
Why?
| | Injections, Intraventricular | 2 | 2009 | 72 | 0.150 |
Why?
| | Trauma and Stressor Related Disorders | 1 | 2017 | 2 | 0.150 |
Why?
| | Amphibians | 1 | 1998 | 47 | 0.150 |
Why?
| | Food Chain | 1 | 2017 | 34 | 0.150 |
Why?
| | Desipramine | 2 | 2015 | 9 | 0.150 |
Why?
| | Genetic Fitness | 1 | 2018 | 54 | 0.140 |
Why?
| | Noise | 1 | 2018 | 66 | 0.140 |
Why?
| | Altitude | 1 | 2021 | 409 | 0.140 |
Why?
| | Receptors, Glucocorticoid | 2 | 2017 | 144 | 0.140 |
Why?
| | Tyrosine | 1 | 2018 | 219 | 0.140 |
Why?
| | Impulsive Behavior | 1 | 2018 | 109 | 0.140 |
Why?
| | Songbirds | 1 | 2018 | 39 | 0.140 |
Why?
| | Helicobacter | 1 | 2016 | 5 | 0.140 |
Why?
| | Sequence Analysis, DNA | 1 | 2020 | 732 | 0.140 |
Why?
| | Soil Microbiology | 1 | 2019 | 176 | 0.140 |
Why?
| | Hydrocortisone | 2 | 2018 | 273 | 0.140 |
Why?
| | Psychomotor Performance | 1 | 2019 | 278 | 0.140 |
Why?
| | Gliadin | 1 | 2016 | 12 | 0.140 |
Why?
| | Lipids | 1 | 2020 | 588 | 0.140 |
Why?
| | Video Recording | 2 | 2009 | 147 | 0.140 |
Why?
| | Nerve Tissue Proteins | 2 | 2018 | 535 | 0.140 |
Why?
| | Tissue Distribution | 3 | 2006 | 324 | 0.140 |
Why?
| | Affect | 1 | 2018 | 244 | 0.140 |
Why?
| | Immunity, Cellular | 1 | 2018 | 262 | 0.140 |
Why?
| | Drug Administration Routes | 2 | 2007 | 41 | 0.130 |
Why?
| | Down-Regulation | 1 | 2018 | 601 | 0.130 |
Why?
| | Species Specificity | 3 | 2023 | 552 | 0.130 |
Why?
| | Epilepsy | 1 | 2020 | 290 | 0.130 |
Why?
| | Rectum | 1 | 2017 | 151 | 0.130 |
Why?
| | Biogenic Amines | 1 | 1996 | 4 | 0.130 |
Why?
| | Sick Building Syndrome | 1 | 2015 | 4 | 0.130 |
Why?
| | Cross-Sectional Studies | 2 | 2024 | 4435 | 0.130 |
Why?
| | Adrenal Glands | 2 | 2016 | 72 | 0.130 |
Why?
| | Combined Modality Therapy | 1 | 2018 | 1127 | 0.130 |
Why?
| | Urban Population | 1 | 2018 | 405 | 0.130 |
Why?
| | Membrane Potentials | 1 | 1996 | 251 | 0.130 |
Why?
| | Leukocytes, Mononuclear | 1 | 2018 | 501 | 0.130 |
Why?
| | Radioimmunoassay | 2 | 2009 | 163 | 0.130 |
Why?
| | Staining and Labeling | 2 | 2006 | 139 | 0.130 |
Why?
| | Sleep | 4 | 2021 | 625 | 0.130 |
Why?
| | Learning | 1 | 2019 | 358 | 0.120 |
Why?
| | Hypoxia | 1 | 2021 | 937 | 0.120 |
Why?
| | Argonaute Proteins | 1 | 2014 | 28 | 0.120 |
Why?
| | Feedback, Physiological | 1 | 2015 | 73 | 0.120 |
Why?
| | Rural Population | 1 | 2018 | 447 | 0.120 |
Why?
| | Alzheimer Disease | 1 | 2020 | 438 | 0.120 |
Why?
| | White Matter | 1 | 2016 | 103 | 0.120 |
Why?
| | Receptors, Steroid | 1 | 1995 | 52 | 0.120 |
Why?
| | Metabolic Networks and Pathways | 1 | 2015 | 168 | 0.120 |
Why?
| | Receptors, Adrenergic, beta-1 | 1 | 2014 | 53 | 0.120 |
Why?
| | Extracellular Space | 2 | 2019 | 122 | 0.120 |
Why?
| | Chronic Disease | 2 | 2019 | 1598 | 0.120 |
Why?
| | Urbanization | 1 | 2014 | 23 | 0.120 |
Why?
| | Cognitive Dysfunction | 1 | 2018 | 279 | 0.120 |
Why?
| | Oncogene Proteins v-fos | 1 | 2013 | 12 | 0.110 |
Why?
| | Proteins | 1 | 2020 | 920 | 0.110 |
Why?
| | Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2014 | 49 | 0.110 |
Why?
| | Bradycardia | 2 | 2012 | 48 | 0.110 |
Why?
| | Biological Evolution | 2 | 2014 | 417 | 0.110 |
Why?
| | Comorbidity | 2 | 2017 | 1473 | 0.110 |
Why?
| | Follow-Up Studies | 3 | 2018 | 4440 | 0.110 |
Why?
| | Emigration and Immigration | 1 | 2014 | 44 | 0.110 |
Why?
| | Antidepressive Agents, Tricyclic | 1 | 2013 | 29 | 0.110 |
Why?
| | Skin | 3 | 2023 | 662 | 0.110 |
Why?
| | Respiration Disorders | 1 | 2014 | 68 | 0.110 |
Why?
| | Receptors, Opioid | 2 | 1990 | 19 | 0.110 |
Why?
| | Weight Gain | 2 | 2019 | 453 | 0.110 |
Why?
| | Receptors, Angiotensin | 1 | 2013 | 10 | 0.110 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 3 | 2021 | 795 | 0.110 |
Why?
| | Rodentia | 1 | 2013 | 44 | 0.110 |
Why?
| | Deoxyadenine Nucleotides | 1 | 2013 | 13 | 0.110 |
Why?
| | Body Weight | 1 | 2017 | 867 | 0.110 |
Why?
| | Amphetamine | 1 | 2012 | 22 | 0.110 |
Why?
| | Pilot Projects | 1 | 2017 | 1377 | 0.110 |
Why?
| | Young Adult | 5 | 2019 | 10470 | 0.110 |
Why?
| | Avoidance Learning | 1 | 2013 | 62 | 0.110 |
Why?
| | Adrenocorticotropic Hormone | 2 | 2011 | 148 | 0.110 |
Why?
| | Resilience, Psychological | 1 | 2014 | 98 | 0.110 |
Why?
| | Angiotensin II | 1 | 2013 | 91 | 0.110 |
Why?
| | Serotonin 5-HT1 Receptor Agonists | 1 | 2012 | 3 | 0.100 |
Why?
| | Sodium Lactate | 2 | 2013 | 5 | 0.100 |
Why?
| | Phenotype | 3 | 2021 | 2829 | 0.100 |
Why?
| | Weaning | 1 | 2012 | 48 | 0.100 |
Why?
| | Brain Injuries | 1 | 2017 | 451 | 0.100 |
Why?
| | Cohort Studies | 2 | 2019 | 4944 | 0.100 |
Why?
| | Homeostasis | 1 | 2015 | 577 | 0.100 |
Why?
| | Memory | 3 | 2018 | 211 | 0.100 |
Why?
| | Quality of Life | 1 | 2022 | 2385 | 0.100 |
Why?
| | Hypertension | 2 | 2012 | 1064 | 0.100 |
Why?
| | Electroshock | 3 | 2017 | 140 | 0.090 |
Why?
| | Cell Line, Transformed | 1 | 2011 | 133 | 0.090 |
Why?
| | Signal Transduction | 2 | 2015 | 4541 | 0.090 |
Why?
| | Environmental Exposure | 1 | 2014 | 378 | 0.090 |
Why?
| | Sanitation | 1 | 2010 | 52 | 0.090 |
Why?
| | Neuronal Tract-Tracers | 1 | 2010 | 2 | 0.090 |
Why?
| | Gene-Environment Interaction | 1 | 2012 | 184 | 0.090 |
Why?
| | Receptor, Serotonin, 5-HT2A | 1 | 2010 | 19 | 0.090 |
Why?
| | Substance Withdrawal Syndrome | 1 | 2012 | 160 | 0.090 |
Why?
| | Receptors, Adrenergic | 2 | 2006 | 36 | 0.090 |
Why?
| | Cell Lineage | 1 | 2012 | 310 | 0.090 |
Why?
| | Diet | 3 | 2023 | 1072 | 0.090 |
Why?
| | Radiography | 1 | 2013 | 826 | 0.090 |
Why?
| | Injections, Intraperitoneal | 2 | 2009 | 104 | 0.090 |
Why?
| | Feeding Behavior | 2 | 2006 | 573 | 0.090 |
Why?
| | Catheters, Indwelling | 1 | 2010 | 79 | 0.090 |
Why?
| | Social Dominance | 1 | 2009 | 17 | 0.080 |
Why?
| | Tyrosine 3-Monooxygenase | 2 | 2007 | 68 | 0.080 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2012 | 388 | 0.080 |
Why?
| | Aromatic Amino Acid Decarboxylase Inhibitors | 1 | 2009 | 1 | 0.080 |
Why?
| | Green Fluorescent Proteins | 1 | 2011 | 377 | 0.080 |
Why?
| | Neuropsychological Tests | 2 | 2020 | 919 | 0.080 |
Why?
| | Thermosensing | 1 | 2008 | 10 | 0.080 |
Why?
| | Pyridines | 2 | 2013 | 425 | 0.080 |
Why?
| | Transfection | 1 | 2011 | 866 | 0.080 |
Why?
| | Temperature | 1 | 2011 | 587 | 0.080 |
Why?
| | Immune Tolerance | 1 | 2010 | 332 | 0.080 |
Why?
| | Pargyline | 1 | 2008 | 2 | 0.080 |
Why?
| | Biological Transport | 2 | 2006 | 375 | 0.080 |
Why?
| | Seroepidemiologic Studies | 2 | 2019 | 140 | 0.080 |
Why?
| | Mice, Transgenic | 4 | 2014 | 1970 | 0.080 |
Why?
| | N-Methyl-3,4-methylenedioxyamphetamine | 1 | 2008 | 10 | 0.080 |
Why?
| | T-Lymphocyte Subsets | 1 | 2010 | 383 | 0.080 |
Why?
| | Central Nervous System Stimulants | 2 | 2012 | 140 | 0.080 |
Why?
| | Somatoform Disorders | 1 | 2007 | 37 | 0.070 |
Why?
| | Synapses | 1 | 2010 | 336 | 0.070 |
Why?
| | Seasons | 2 | 2020 | 449 | 0.070 |
Why?
| | Acoustic Stimulation | 1 | 2009 | 313 | 0.070 |
Why?
| | Aged | 3 | 2024 | 19251 | 0.070 |
Why?
| | Statistics as Topic | 1 | 2008 | 299 | 0.070 |
Why?
| | Bronchopulmonary Sequestration | 1 | 2007 | 9 | 0.070 |
Why?
| | Amino Acid Sequence | 1 | 2011 | 2000 | 0.070 |
Why?
| | Tryptamines | 1 | 2006 | 3 | 0.070 |
Why?
| | Dose-Response Relationship, Radiation | 1 | 2007 | 130 | 0.070 |
Why?
| | Darkness | 1 | 2006 | 23 | 0.070 |
Why?
| | Evidence-Based Medicine | 1 | 2010 | 684 | 0.070 |
Why?
| | Tegmentum Mesencephali | 1 | 2006 | 4 | 0.070 |
Why?
| | Tissue Fixation | 1 | 2005 | 28 | 0.070 |
Why?
| | Chromatography, Liquid | 2 | 2021 | 347 | 0.070 |
Why?
| | Blood-Brain Barrier | 1 | 2006 | 106 | 0.060 |
Why?
| | Blood Pressure | 2 | 2013 | 1537 | 0.060 |
Why?
| | Cell Membrane | 2 | 2022 | 683 | 0.060 |
Why?
| | Peptide Fragments | 2 | 2008 | 675 | 0.060 |
Why?
| | Drug Interactions | 1 | 2007 | 347 | 0.060 |
Why?
| | Median Eminence | 1 | 2005 | 4 | 0.060 |
Why?
| | Arcuate Nucleus of Hypothalamus | 1 | 2005 | 13 | 0.060 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2009 | 691 | 0.060 |
Why?
| | Stilbamidines | 1 | 2005 | 10 | 0.060 |
Why?
| | Injections | 1 | 2005 | 161 | 0.060 |
Why?
| | Heart Atria | 1 | 2005 | 110 | 0.060 |
Why?
| | Adrenergic alpha-Antagonists | 1 | 2005 | 30 | 0.060 |
Why?
| | Autoimmunity | 1 | 2010 | 822 | 0.060 |
Why?
| | Perfusion | 1 | 2005 | 150 | 0.060 |
Why?
| | Microinjections | 2 | 2015 | 78 | 0.060 |
Why?
| | Nerve Fibers | 1 | 2005 | 87 | 0.060 |
Why?
| | Neurons, Efferent | 1 | 2004 | 8 | 0.060 |
Why?
| | Genes, Immediate-Early | 1 | 2004 | 18 | 0.060 |
Why?
| | Genotype | 2 | 2020 | 1786 | 0.060 |
Why?
| | Lomustine | 1 | 2024 | 14 | 0.060 |
Why?
| | Pregnancy | 4 | 2022 | 5548 | 0.060 |
Why?
| | Sympathetic Nervous System | 1 | 2005 | 171 | 0.060 |
Why?
| | Action Potentials | 2 | 2011 | 410 | 0.060 |
Why?
| | Prednisone | 1 | 2024 | 232 | 0.050 |
Why?
| | Blood Glucose | 2 | 2011 | 1824 | 0.050 |
Why?
| | Rats, Inbred Lew | 1 | 2003 | 93 | 0.050 |
Why?
| | Psychiatric Status Rating Scales | 2 | 2016 | 485 | 0.050 |
Why?
| | Immunoglobulin M | 1 | 2024 | 254 | 0.050 |
Why?
| | Carbidopa | 1 | 2022 | 4 | 0.050 |
Why?
| | Orexin Receptors | 2 | 2012 | 3 | 0.050 |
Why?
| | Psychoneuroimmunology | 1 | 2022 | 12 | 0.050 |
Why?
| | Exercise | 1 | 2012 | 1609 | 0.050 |
Why?
| | Polysomnography | 2 | 2019 | 135 | 0.050 |
Why?
| | Receptors, Interleukin-6 | 1 | 2022 | 34 | 0.050 |
Why?
| | Models, Biological | 2 | 2007 | 1646 | 0.050 |
Why?
| | Fathers | 1 | 2022 | 45 | 0.050 |
Why?
| | Blotting, Western | 1 | 2005 | 1153 | 0.050 |
Why?
| | Bacteroidetes | 1 | 2021 | 20 | 0.050 |
Why?
| | Endophenotypes | 1 | 2021 | 16 | 0.050 |
Why?
| | Social Justice | 1 | 2022 | 66 | 0.050 |
Why?
| | Anhedonia | 1 | 2021 | 9 | 0.050 |
Why?
| | Supervised Machine Learning | 1 | 2021 | 11 | 0.050 |
Why?
| | Pregnancy Trimester, First | 1 | 2022 | 127 | 0.050 |
Why?
| | Granulocytes | 1 | 2021 | 78 | 0.050 |
Why?
| | Biodegradation, Environmental | 1 | 2021 | 80 | 0.050 |
Why?
| | Microfilament Proteins | 1 | 2022 | 126 | 0.050 |
Why?
| | Nontuberculous Mycobacteria | 1 | 2023 | 207 | 0.050 |
Why?
| | Dietary Sucrose | 1 | 2021 | 45 | 0.050 |
Why?
| | Trees | 1 | 2021 | 62 | 0.050 |
Why?
| | Rivers | 1 | 2021 | 54 | 0.050 |
Why?
| | Dreams | 1 | 2000 | 10 | 0.050 |
Why?
| | Diagnostic and Statistical Manual of Mental Disorders | 1 | 2021 | 230 | 0.050 |
Why?
| | Microelectrodes | 1 | 2000 | 32 | 0.050 |
Why?
| | Cations | 1 | 2021 | 79 | 0.050 |
Why?
| | Choice Behavior | 1 | 2022 | 159 | 0.050 |
Why?
| | Cattle | 1 | 2023 | 935 | 0.050 |
Why?
| | Policy | 1 | 2022 | 140 | 0.050 |
Why?
| | Calcium-Binding Proteins | 1 | 2022 | 203 | 0.050 |
Why?
| | Toll-Like Receptor 4 | 1 | 2023 | 285 | 0.040 |
Why?
| | Positive-Pressure Respiration | 1 | 2000 | 68 | 0.040 |
Why?
| | Benzomorphans | 2 | 1990 | 2 | 0.040 |
Why?
| | Cathelicidins | 1 | 2020 | 39 | 0.040 |
Why?
| | Metagenomics | 1 | 2021 | 131 | 0.040 |
Why?
| | DNA, Ribosomal | 1 | 2020 | 80 | 0.040 |
Why?
| | Sleep Apnea Syndromes | 1 | 2000 | 74 | 0.040 |
Why?
| | ROC Curve | 1 | 2021 | 451 | 0.040 |
Why?
| | Antimicrobial Cationic Peptides | 1 | 2020 | 76 | 0.040 |
Why?
| | Chromosome Mapping | 1 | 2020 | 489 | 0.040 |
Why?
| | Patient Care Team | 1 | 2024 | 521 | 0.040 |
Why?
| | Asthma | 1 | 2012 | 2066 | 0.040 |
Why?
| | Normetanephrine | 1 | 2019 | 2 | 0.040 |
Why?
| | Lymphocytes | 1 | 2021 | 344 | 0.040 |
Why?
| | Electroencephalography | 1 | 2021 | 365 | 0.040 |
Why?
| | Interpersonal Relations | 2 | 2015 | 342 | 0.040 |
Why?
| | Administration, Intranasal | 1 | 2019 | 75 | 0.040 |
Why?
| | Photic Stimulation | 1 | 2020 | 203 | 0.040 |
Why?
| | Dextran Sulfate | 1 | 2019 | 70 | 0.040 |
Why?
| | Reaction Time | 1 | 2000 | 373 | 0.040 |
Why?
| | Social Environment | 2 | 2010 | 286 | 0.040 |
Why?
| | Axons | 1 | 2000 | 179 | 0.040 |
Why?
| | Tandem Mass Spectrometry | 1 | 2021 | 414 | 0.040 |
Why?
| | Patient-Centered Care | 1 | 2024 | 477 | 0.040 |
Why?
| | Optogenetics | 1 | 2020 | 95 | 0.040 |
Why?
| | Metabolome | 1 | 2021 | 287 | 0.040 |
Why?
| | Wakefulness | 1 | 2019 | 128 | 0.040 |
Why?
| | Quantitative Trait Loci | 1 | 2020 | 313 | 0.040 |
Why?
| | Task Performance and Analysis | 1 | 2019 | 160 | 0.040 |
Why?
| | Serologic Tests | 1 | 2018 | 51 | 0.040 |
Why?
| | Extracellular Fluid | 2 | 2010 | 31 | 0.040 |
Why?
| | Germany | 1 | 2018 | 86 | 0.040 |
Why?
| | Agoraphobia | 1 | 2017 | 6 | 0.040 |
Why?
| | Patient Reported Outcome Measures | 1 | 2020 | 250 | 0.040 |
Why?
| | Feathers | 1 | 2018 | 35 | 0.040 |
Why?
| | Nucleic Acid Probes | 1 | 1997 | 1 | 0.040 |
Why?
| | Ethylmaleimide | 1 | 1997 | 18 | 0.040 |
Why?
| | Risk Factors | 2 | 2024 | 8697 | 0.040 |
Why?
| | Thionucleotides | 1 | 1997 | 34 | 0.040 |
Why?
| | Inhibitory Postsynaptic Potentials | 1 | 2017 | 32 | 0.040 |
Why?
| | Biodiversity | 1 | 2021 | 363 | 0.040 |
Why?
| | Dogs | 1 | 2018 | 341 | 0.040 |
Why?
| | Body Size | 1 | 2018 | 92 | 0.040 |
Why?
| | Healthy Volunteers | 1 | 2018 | 192 | 0.040 |
Why?
| | Nerve Net | 1 | 2020 | 228 | 0.040 |
Why?
| | Picrotoxin | 1 | 2017 | 13 | 0.040 |
Why?
| | Oxytocin | 1 | 1997 | 45 | 0.040 |
Why?
| | Quinolines | 2 | 2010 | 129 | 0.040 |
Why?
| | Computational Biology | 1 | 2020 | 536 | 0.030 |
Why?
| | Arizona | 1 | 2016 | 67 | 0.030 |
Why?
| | Anisotropy | 1 | 2016 | 62 | 0.030 |
Why?
| | Attention | 1 | 2019 | 394 | 0.030 |
Why?
| | Self Report | 1 | 2020 | 698 | 0.030 |
Why?
| | 5,7-Dihydroxytryptamine | 1 | 2015 | 3 | 0.030 |
Why?
| | Adrenergic Uptake Inhibitors | 1 | 2015 | 13 | 0.030 |
Why?
| | Diffusion Tensor Imaging | 1 | 2016 | 66 | 0.030 |
Why?
| | Organ Size | 1 | 2016 | 434 | 0.030 |
Why?
| | Genomics | 1 | 2020 | 645 | 0.030 |
Why?
| | Thymus Gland | 1 | 2016 | 299 | 0.030 |
Why?
| | 11-beta-Hydroxysteroid Dehydrogenase Type 1 | 1 | 2014 | 6 | 0.030 |
Why?
| | Executive Function | 1 | 2019 | 373 | 0.030 |
Why?
| | Rabbits | 1 | 2016 | 752 | 0.030 |
Why?
| | Environment | 1 | 2017 | 337 | 0.030 |
Why?
| | Freezing Reaction, Cataleptic | 1 | 2014 | 23 | 0.030 |
Why?
| | Enzyme Inhibitors | 1 | 2018 | 757 | 0.030 |
Why?
| | Mifepristone | 1 | 2014 | 65 | 0.030 |
Why?
| | Calcium | 1 | 2000 | 1103 | 0.030 |
Why?
| | Mice, Inbred ICR | 1 | 2014 | 111 | 0.030 |
Why?
| | Glutamic Acid | 1 | 2016 | 213 | 0.030 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2018 | 289 | 0.030 |
Why?
| | Colorado | 1 | 2024 | 4113 | 0.030 |
Why?
| | Self-Injurious Behavior | 1 | 2015 | 114 | 0.030 |
Why?
| | Immune System Diseases | 1 | 2014 | 35 | 0.030 |
Why?
| | Electrochemical Techniques | 1 | 2014 | 46 | 0.030 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2016 | 482 | 0.030 |
Why?
| | Mothers | 1 | 1999 | 666 | 0.030 |
Why?
| | Catalysis | 1 | 2014 | 299 | 0.030 |
Why?
| | Memory Disorders | 1 | 2014 | 155 | 0.030 |
Why?
| | Heterozygote | 1 | 2014 | 252 | 0.030 |
Why?
| | Receptors, Opioid, kappa | 2 | 1990 | 11 | 0.030 |
Why?
| | Adaptation, Physiological | 2 | 2009 | 476 | 0.030 |
Why?
| | Angiotensin II Type 2 Receptor Blockers | 1 | 2013 | 7 | 0.030 |
Why?
| | Pandemics | 1 | 2021 | 1334 | 0.030 |
Why?
| | Cues | 1 | 2015 | 297 | 0.030 |
Why?
| | Genome-Wide Association Study | 1 | 2019 | 1217 | 0.030 |
Why?
| | Angiotensin II Type 1 Receptor Blockers | 1 | 2013 | 29 | 0.030 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2020 | 1918 | 0.030 |
Why?
| | Odds Ratio | 1 | 2015 | 962 | 0.030 |
Why?
| | Sex Factors | 1 | 2018 | 1736 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2019 | 2416 | 0.030 |
Why?
| | Naloxone | 2 | 1990 | 99 | 0.030 |
Why?
| | Orexins | 1 | 2012 | 4 | 0.030 |
Why?
| | Androgens | 1 | 1994 | 165 | 0.030 |
Why?
| | Naphthyridines | 1 | 2012 | 16 | 0.030 |
Why?
| | Benzoxazoles | 1 | 2012 | 16 | 0.030 |
Why?
| | Urea | 1 | 2012 | 69 | 0.020 |
Why?
| | Imidazoles | 1 | 2013 | 217 | 0.020 |
Why?
| | Fetal Development | 1 | 2014 | 247 | 0.020 |
Why?
| | Respiration | 1 | 2012 | 177 | 0.020 |
Why?
| | Muscle Strength | 1 | 2014 | 275 | 0.020 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2012 | 317 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2018 | 2800 | 0.020 |
Why?
| | Estrogens | 1 | 1994 | 315 | 0.020 |
Why?
| | Specific Pathogen-Free Organisms | 1 | 2010 | 60 | 0.020 |
Why?
| | Morphinans | 1 | 1989 | 7 | 0.020 |
Why?
| | Receptors, Opioid, mu | 1 | 1990 | 52 | 0.020 |
Why?
| | Organic Chemicals | 1 | 2010 | 116 | 0.020 |
Why?
| | Mass Screening | 1 | 2016 | 1024 | 0.020 |
Why?
| | Heart Rate | 1 | 2013 | 701 | 0.020 |
Why?
| | Morphine | 1 | 1990 | 124 | 0.020 |
Why?
| | Allylglycine | 1 | 2007 | 2 | 0.020 |
Why?
| | Child | 2 | 2019 | 18488 | 0.020 |
Why?
| | Choline O-Acetyltransferase | 1 | 2007 | 24 | 0.020 |
Why?
| | Phosphopyruvate Hydratase | 1 | 2007 | 30 | 0.020 |
Why?
| | Electric Stimulation | 1 | 2008 | 263 | 0.020 |
Why?
| | Pain | 1 | 2013 | 712 | 0.020 |
Why?
| | Glutamate Decarboxylase | 1 | 2007 | 162 | 0.020 |
Why?
| | Pyrroles | 1 | 2008 | 185 | 0.020 |
Why?
| | Autonomic Nervous System | 1 | 2007 | 70 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2014 | 3914 | 0.020 |
Why?
| | 1-Methyl-4-phenylpyridinium | 1 | 2006 | 5 | 0.020 |
Why?
| | Obesity | 1 | 2019 | 2517 | 0.020 |
Why?
| | Neural Inhibition | 1 | 2007 | 152 | 0.020 |
Why?
| | Cimetidine | 1 | 1986 | 15 | 0.020 |
Why?
| | Ranitidine | 1 | 1986 | 13 | 0.020 |
Why?
| | Growth Hormone | 1 | 1986 | 99 | 0.020 |
Why?
| | Pyrimidines | 1 | 2008 | 376 | 0.020 |
Why?
| | Testis | 1 | 1986 | 134 | 0.020 |
Why?
| | Statistics, Nonparametric | 1 | 2005 | 390 | 0.020 |
Why?
| | Inspiratory Capacity | 1 | 2004 | 2 | 0.010 |
Why?
| | Genetic Predisposition to Disease | 1 | 2012 | 2125 | 0.010 |
Why?
| | Mutation | 1 | 2014 | 3364 | 0.010 |
Why?
| | Single-Blind Method | 1 | 2004 | 255 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2016 | 9159 | 0.010 |
Why?
| | Reference Values | 1 | 2004 | 744 | 0.010 |
Why?
| | Periodicity | 1 | 2000 | 56 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2017 | 12608 | 0.010 |
Why?
| | Pyramidal Cells | 1 | 1999 | 51 | 0.010 |
Why?
| | Atrophy | 1 | 1999 | 152 | 0.010 |
Why?
| | Progesterone | 1 | 1999 | 232 | 0.010 |
Why?
| | Neuronal Plasticity | 1 | 1999 | 214 | 0.010 |
Why?
| | RNA, Complementary | 1 | 1997 | 2 | 0.010 |
Why?
| | Sulfur Radioisotopes | 1 | 1997 | 17 | 0.010 |
Why?
| | Thyrotropin-Releasing Hormone | 1 | 1997 | 12 | 0.010 |
Why?
| | Oligonucleotide Probes | 1 | 1997 | 54 | 0.010 |
Why?
| | Estradiol | 1 | 1999 | 452 | 0.010 |
Why?
| | Body Mass Index | 1 | 2000 | 1971 | 0.010 |
Why?
| | Testosterone | 1 | 1994 | 337 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2000 | 4665 | 0.010 |
Why?
| | Dyspepsia | 1 | 1986 | 9 | 0.000 |
Why?
| | Gonadal Steroid Hormones | 1 | 1986 | 124 | 0.000 |
Why?
| | Glucose Tolerance Test | 1 | 1986 | 344 | 0.000 |
Why?
| | Insulin | 1 | 1986 | 2082 | 0.000 |
Why?
|
|
Lowry's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|